Jolife AB signs world wide agreement with MEDTRONIC to distribute LUCAS, a CPR assistance device
Lund, 2nd of December, 2004
Jolife AB, a cardiac research company based in LUND, SWEDEN, has recently signed an agreement with Medtronic Inc., to distribute its LUCAS cardio pulmonary resuscitation (CPR) assist device, a product under CE mark regulatory approval. Medtronic's Emergency Response Systems business unit is now distributing the product in all Nordic countries. Distribution of the product to other European countries will begin in 2005. LUCAS will be available in other countries during 2005 and 2006.
Carrying out chest compressions with proper rate, rhythm, and depth to help resuscitate a cardiac arrest patient is difficult, especially over longer periods of time. Jolife's chest compression system, LUCAS, developed and manufactured in Sweden ensures chest compressions will be carried out properly allowing a rescuer to focus on other life-saving tasks. "LUCAS is a form of treatment which has achieved a lot of scientific interest recently" says Erik von Schenck, Jolife's MD. "The product is an ideal complement to Medtronic LIFEPAK external defibrillators. LUCAS is today well established on the Swedish and English markets. Our product is now available to all of our Nordic neighbours, and then the rest of Europe."
Cardiac arrest is a common cause of death
Sudden pre-hospital cardiac arrest is one of the leading causes of death worldwide. In Europe, the annual death toll averages about 375,000. It's estimated that over 95 percent of cardiac arrest victims die before reaching the hospital. Time delay in trained personnel reaching a cardiac arrest patient is one of the main causes of such high mortality. This means a lot of responsibility rests with bystanders who witness the cardiac arrest. It is important to start chest compressions quickly while waiting for the ambulance.
Jolife is a research-intensive start-up company within medical technology, established at Ideon Science Park. The company was formed in 2000, and has since been working with research and development within the area of resuscitation. The research is carried out in close co-operation with Lund University. Jolife's goal is to develop and market a system of products and methods for increasing the survival of people who had a cardiac arrest. LUCAS has been on the Swedish market since 2003. Principal owners of the company are Lars Sunnanväder, Innovationskapital and Cap man.
For further information, contact:
Erik von Schenck MD, Jolife AB +46 (0)733-14 74 71
This press release put out by:
223 70 LUND
046-286 50 00